(Total Views: 68)
Posted On: 09/16/2019 11:23:31 AM
Post# of 250662
$CYDY CytoDyn a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. #CYDY
Annual shareholders meeting update.
https://www.cytodyn.com/newsroom/press-releas...meeting-of
Annual shareholders meeting update.
https://www.cytodyn.com/newsroom/press-releas...meeting-of
(0)
(0)
